BIND Therapeutics: Cowen and Company Healthcare Conference (BIND Therapeutics) - Mar 5, 2015 - Anticipated final data from P2 trial (NCT01792479) in KRAS+ NSCLC in 2015/H1 2016; Anticipated final data from P2 trial (NCT02283320) in squamous NSCLC in 2015/H1 2016
Anticipated P2 data • Non Small Cell Lung Cancer • Oncology
|